Why is Suven Life Scie. falling/rising?

As of 22-Jul, Suven Life Sciences Ltd is currently priced at 288.00, reflecting a decrease of 0.9 (-0.31%). The stock has shown a mixed performance recently, with a 1-week decline of 3.19%, although it has significantly outperformed the market with a 26.90% increase over the past month and an impressive 123.86% year-to-date return. Today's performance indicates that the stock has outperformed its sector by 0.6%, but there is a notable decline in investor participation, with delivery volume falling by 82.08% compared to the 5-day average. Despite the strong long-term performance, the company faces challenges, including operating losses and a weak long-term fundamental strength, as evidenced by a significant decline in net sales and operating profit over the past five years. Additionally, the company has reported negative results for the last three consecutive quarters, which may contribute to the stock's recent downward movement.
In the broader market context, the stock's short-term performance has been less favorable compared to the benchmark, as it has declined by 3.19% over the past week while the Sensex has only decreased by 0.47%. This underperformance in the short term contrasts sharply with its strong long-term returns, where it has outperformed the BSE500 over the last three years, one year, and three months. The decline in institutional investor participation, with a decrease in their stake by 1.13%, further indicates a lack of confidence in the company's fundamentals, which could be influencing the stock's price movement negatively.